default author photo

Hongzhen Li

Joinn Laboratories Co. Ltd. - Beijing Key Laboratory of Bio-products Safety Assessment

Beijing, 100176

China

SCHOLARLY PAPERS

1

DOWNLOADS

157

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Heparin-Induced Thrombocytopenia Is a High Risk of Mortality in Critical COVID-19 Patients Receiving Heparin-Involved Treatment

Number of pages: 22 Posted: 12 May 2020
Xuan Liu, Xiaopeng Zhang, Yongjiu Xiao, Ting Gao, Guangfei Wang, Zhongyi Wang, Zhang Zhang, Yong Hu, Qincai Dong, Songtao Zhao, Li Yu, Shuwei Zhang, Hongzhen Li, Kaitong Li, Wei Chen, Xiuwu Bian, Qing Mao and Cheng Cao
Beijing Institute of Biotechnology, Beijing Institute of Biotechnology, Government of the People's Republic of China - 940th Hospital of Joint Logistics Support Force of PLA, Beijing Institute of Biotechnology, Beijing Institute of Biotechnology, Beijing Institute of Biotechnology, Beijing Institute of Biotechnology, Beijing Institute of Biotechnology, Beijing Institute of Biotechnology, Government of the People's Republic of China - First Affiliated Hospital, Government of the People's Republic of China - 969th Hospital, Beijing Institute of Biotechnology, Joinn Laboratories Co. Ltd. - Beijing Key Laboratory of Bio-products Safety Assessment, Joinn Laboratories Co. Ltd. - Beijing Key Laboratory of Bio-products Safety Assessment, Academy of Military Medical Sciences - Institute of Biotechnology, Government of the People's Republic of China - Southwest Hospital, Third Military Medical University, Southwest Hospital, Department of Infectious Diseases and Beijing Institute of Biotechnology
Downloads 157 (482,968)
Citation 1

Abstract:

Loading...

COVID-19, platelet, thrombocytopenia, heparin-induced thrombocytopenia, continuous renal replacement therapy